High-Expenditure Disease in the EU-28: Does Drug Spend Correspond to Clinical and Economic Burden in Oncology, Autoimmune Disease and Diabetes?

Wolfgang GreinerKeyur PatelChristina-Jane Crossman-BarnesTroels Vingtoft Rye-AndersenChristian HvidTom Vandebrouck

Published in: PharmacoEconomics - open (2021)

This study indicates that drug spend may not correlate to clinical burden across diseases. Future research could stimulate debate on whether more equitable drug funding may improve disease management.

Keyphrases

type diabetes
cardiovascular disease
drug induced
palliative care
multiple sclerosis
adverse drug
metabolic syndrome
adipose tissue